PCN2: DOSES OF OLANZPINE, RISPERIDONE, AND HALOPERIDOL IN CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE PHARMACOEOPIDEMIOGICAL STUDY (EFESO) — J A Sacristán (1999) | RDL Network
Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos, Michèle Cavo, Sandra Lejniece, Meral Beksaç, Mohamed Amine Bekadja, Wojciech Legieć, Meletios A Dimopoulos, Svetlana Stankovic, María Soledad Durán, Valerio De Stefano, Alessandro Corso, Yulia Kochkareva, Edward Laane, Christian Berthou, Hans Salwender, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, João Pedro Silva, Vernon Louw, ,
Jannet A. Eindhoven, Yoshinobu Onuma, Rohit M. Oemrawsingh, Joost Daemen, Josephine van Nierop, Peter de Jaegere, Eric Boersma, Patrick W. Serruys, Ron van Domburg
Luciana Ambrosiani, Massimo Filippi, Franco Radaelli, Emanuele Rondonotti, Cesare Hassan, Giacomo Tamanini, Giulio Antonelli, Gianluca Andrisani, G Leonetti, Silvia Paggi, Arnaldo Amato, G. Scardino, Paolo Declich, G. Mandelli, Nicoletta Lenoci, N. Terreni, Alida Andrealli, Marco Spadaccini, Roberta Maselli, P.A. Galtieri, Francesco Maria Di Matteo, Alessandro Repici
Discussion(0)
No comments yet. Be the first to comment.